MET mutations boost #TumorImmunogenicity, enhance immune infiltration, and improve responses to #ImmuneCheckpointInhibitors, serving as independent #biomarkers for survival and guiding #PersonalizedImmunotherapy across cancers.
#OpenAccess: doi.org/10.1016/j.ge...